XML 29 R13.htm IDEA: XBRL DOCUMENT
v3.25.4

Acquisitions and Dispositions | 12 Months Ended
--- | ---
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract] |
Acquisitions and Dispositions | Acquisitions and Dispositions Dispositions In connection with the separation and distribution of Concentra’s common stock, the Company and Concentra entered into several agreements to provide a framework of our ongoing relationship with Concentra, including a transition services agreement (“TSA”), a separation agreement, a tax matters agreement and an employee matters agreement. The services under the TSA generally are a continuation of the support services provided by Select to Concentra prior to the IPO. The fee for support services provided to Concentra was $1.2 million and $12.1 million for the years ended December 31, 2024 and 2025, respectively. The income from the support services fees, as well as the cost to provide these services, are included within General and Administrative expense on the Consolidated Statements of Operations. The provision of services under the TSA will terminate no later than November 25, 2026. Certain key selected financial information included in Income from discontinued operations, net of tax, for Concentra is as follows:
| For the Year Ended December 31,
| 2023 |  | 2024 |  |
Revenue | $ | 1,838,081 |  |  | $ | 1,738,411 |  |  |
Costs and expenses: |  |  |  |  |
Cost of services, exclusive of depreciation and amortization | 1,477,648 |  |  | 1,374,783 |  |  |
General and administrative | — |  |  | 1,620 |  |  |
Depreciation and amortization | 73,051 |  |  | 61,028 |  |  |
Total costs and expenses | 1,550,699 |  |  | 1,437,431 |  |  |
Other operating income | 250 |  |  | 284 |  |  |
Income from operations | 287,632 |  |  | 301,264 |  |  |
Other income and expense: |  |  |  |  |
Equity in earnings of unconsolidated subsidiaries | (526) |  |  | (3,676) |  |  |
Interest expense(1) | (44,474) |  |  | (59,513) |  |  |
Income from discontinued operations before income taxes | 242,632 |  |  | 238,075 |  |  |
Income tax expense | 53,372 |  |  | 56,756 |  |  |
Income from discontinued operations, net of tax | 189,260 |  |  | 181,319 |  |  |
Less: Net income attributable to non-controlling interests | 4,796 |  |  | 18,152 |  |  |
Income from discontinued operations, net of tax, attributable to Select Medical Holdings Corporation’s common stockholders | $ | 184,464 |  |  | $ | 163,167 |  |  |
_______________________________________________________________________________ (1) For the years ended December 31, 2023 and 2024, interest expense includes allocated interest expense of $44.3 million and $22.0 million, respectively. Interest was allocated in accordance with the terms of an intercompany promissory note in place between the Company and Concentra prior to the separation. The following is selected financial information included on the Consolidated Statements of Cash Flows for Concentra:
| For the Year Ended December 31,
| 2023 |  | 2024 |  |
Depreciation and amortization | 73,051 |  |  | 61,028 |  |  |
Cash flows from investing activities: |  |  |  |  |
Purchases of property, equipment, and other assets | $ | 69,340 |  |  | $ | 63,269 |  |  |
Acquisitions During the year ended December 31, 2023, the Company made acquisitions consisting of critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation businesses. The consideration given for these acquired businesses consisted principally of $23.6 million of cash and the issuance of $9.0 million of non-controlling interests. The Company allocated the purchase price of these acquired businesses to assets acquired and liabilities assumed, principally property and equipment and operating lease right-of-use assets and lease liabilities, based on their estimated fair values. The Company recognized goodwill of $6.6 million, $16.2 million, and $2.3 million in our critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation reporting units, respectively. During the year ended December 31, 2024, the Company made acquisitions consisting of critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation businesses. The consideration given for these acquired businesses consisted of $12.1 million of cash, $20.3 million of previously held equity interests, and $24.5 million for the issuance of non-controlling interests. The Company allocated the purchase price of these acquired businesses to assets acquired and liabilities assumed, principally property and equipment and operating lease right-of-use assets and lease liabilities, based on their estimated fair values. The Company recognized goodwill of $8.0 million, $38.4 million, and $1.7 million in our critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation reporting units, respectively. During the year ended December 31, 2025, the Company made acquisitions consisting of critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation businesses. The consideration given for these acquired businesses consisted of $9.2 million of cash and $20.1 million for the issuance of non-controlling interests. The Company allocated the purchase price of these acquired businesses to assets acquired and liabilities assumed, principally property and equipment and operating lease right-of-use assets and lease liabilities, based on their estimated fair values. The Company recognized goodwill of $7.8 million, $20.5 million, and $0.8 million in our critical illness recovery hospital, rehabilitation hospital, and outpatient rehabilitation reporting units, respectively

X
- References No definition available. + Details
Name: | us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205-20/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/805/tableOfContent + Details
Name: | us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration